An observational study in Vaping and Electronic Cigarette Use, sponsored by Laval University. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-04.
Sponsored by Laval University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Vaping with a site in Canada — 6 open to participants now, 8 under way, 1 of them phase 3. Vaping · Canada.
Among the 13 studies in Vaping with a site in Canada, this one is the only one that started in 2021, is one of 3 observational ones, and was the 8th registered.
404 studies on the registry are indexed under Vaping; 97 are open to participants now.
Browse Vaping studies →6 of the 13 studies in Vaping with a site in Canada are open now. Recruiting first, the newest first:
Centre for Addiction and Mental Health · Sites in Canada
Ages 18–65
University of British Columbia · Sites in Canada
Ages 12+ · Healthy volunteers
Sir Mortimer B. Davis - Jewish General Hospital · Sites in Canada
Ages 18+
Western University, Canada · Sites in Canada
Ages 16+ · Healthy volunteers
University of Alberta · Sites in Canada
Ages 12–40 · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 65 Vaping studies recruiting now, 33 (51%) set no upper age limit and 31 (48%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 1 started in 2021.
This study's planned enrollment of 250 is above the median of 120 across 65 observational studies indexed under Vaping.
Median enrollment 155 across the 10 interventional studies, 250 across the 3 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 13 have an industry lead sponsor. The 10 most frequent:
Laval University is the lead sponsor of 380 studies on the registry; 67 are open to participants now.
Laval University has 1 study filed under Vaping — fewer than ten, so there is no comparison to draw.
1 of the studies in Vaping with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06164678Ottawa Heart Institute Research CorporationVaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Vaping with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective study assesses the pulmonary and cardiovascular effets of vaping in adult electronic cigarette users with biannual visits and a 5-year follow-up.
Daily vaping device users will be recruited in the Quebec City metropolitan area. Subjects will be asked to perform pulmonary function tests (spirometry, oscillometry, plethysmography, methacholine provocation) every 6 months for a 5-year follow up. Subjects will also answer a questionnaire assessing their vaping, tobacco and cannabis smoking habits, as well as their perceived respiratory symptoms. Blood draws and sputum inductions will be performed for cell counts and to measure inflammation markers.
We seek to recruit 250 volunteers from the community with twice-a-year visits for a 5-year follow-up. We will recruit healthy volunteers as well as volunteers who have been previously diagnosed with chronic illness.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants must use their vaping device everyday at time of enrollment.
Other: Vaping
Participants use their vaping products at their own discretion and their intake is monitored via questionnaires.
Number of participants who vape daily with impaired lung volumes.
Participants will perform plethysmography assessments to measure changes in lung volumes. Data will be expressed as a percentage of predicted values.
Time frame: Every 6 months for 5 years
Number of participants who vape daily with impaired lung diffusion capacity.
Participants will perform diffusion capacity of the lung for carbon monoxide (DLCO) measures to assess changes in lung diffusion capacity. Data will be expressed as a percentage of predicted values.
Time frame: Every 6 months for 5 years
Number of participants who vape daily with impaired spirometry.
Participants will perform spirometry tests measures to assess changes in forced expiratory lung volumes. Data will be expressed as a percentage of predicted values.
Time frame: Every 6 months for 5 years
Number of participants who vape daily with airway hyperresponsiveness.
Participants will perform methacholine provocation challenge measures to assess changes in airway hyperresponsiveness. Data will be expressed as the methacholine concentration inducing a fall of 20% of forced expiratory volume in the first second assessed (PC20).
Time frame: Every 6 months for 5 years
Number of participants who vape daily with changes in blood cell count.
Participants will perform a blood draw to assess blood cell count. Data will be expressed as a percentage of eosinophils, neutrophils, macrophages and lymphocytes of the total cell count.
Time frame: Every 6 months for 5 years
Number of participants who vape daily with changes in sputum cell count.
Participants will perform sputum inductions to assess cell count in the sputum. Data will be expressed as a percentage of eosinophils, neutrophils, macrophages and lymphocytes of the total cell count.
Time frame: Every 6 months for 5 years
Vaping, tobacco and cannabis smoking habits of participants.
Participants will complete questionnaires assessing their vaping habits, tobacco smoking and cannabis smoking history.
Time frame: Every 3 months for 5 years
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2021 (actual). Primary completion is estimated for Dec 2031, 122 months after the start.
Of 32 observational studies under Vaping, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 32 and three quarters within 46. This study's planned 122 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.